Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

Zai Lab In-Licenses Cervical Cancer ADC from Seagen for $30 Million Upfront

publication date: Sep 27, 2022

Shanghai Zai Lab formed a collaboration with Seattle’s Seagen to develop a novel treatment for cervical cancer in China. Tivdak® (tisotumab vedotin-tftv) is the only ADC approved in the US for metastatic/recurrent cervical cancer with disease progression. Zai Lab will make a $30 million upfront payment and be responsible for unspecified milestones and royalties. The drug was co-developed by Seagen and Copenhagen’s Genmab, which are conducting a confirmatory Phase III trial. The two companies will split all China revenues 50/50. More details....

Stock Symbols: (NSDQ: ZLAB; HKEX: 9688) (NSDQ: SGEN)

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

Upcoming Events

ChinaBio® Partnering Forum
September 10–11, 2024 | Shanghai, China
Register here


BIO-Europe®
November 4–6, 2024 | Stockholm, Sweden
Save €900 before September 13!
Register here


Biotech Showcase™
January 13–15, 2025 | San Francisco, CA
Save $600 before September 27!
Other Relevant Events

Antibody Engineering & Therapeutics Asia
October 21–23, 2024 | Kyoto, Japan
Save 30% with code CHINABIO30!
Register here